All News

Research in the melanoma space is finding itself facing complex challenges in implementing CAR-T cell therapy, but according to one expert these challenges are not insurmountable.

A survey administered by pharmaceutical company Incyte and the nonprofit Cholangiocarcinoma Foundation found that patients with bile duct cancer face more than a dozen symptoms or treatment-related side effects that negatively affect their daily lives.

One cancer survivor emphatically disagrees with the notion that cancer is now a “chronic” condition.

The FDA’s approval of Tecartus for adults with relapsed or refractory mantle cell lymphoma (MCL) is based on data that showed that the CAR T-cell therapy induced a response in 87% of patients.

Here, a survivor lists some alternative ways that patients with cancer or survivors in need of flexible employment can earn extra money.

From the death of civil rights icon John Lewis to a woman pretending to have cancer as part of a larger donation scam, here’s what’s making the headlines in the cancer space this week.

Patients with multiple myeloma who were obese or overweight had a trend toward slightly improved progression-free survival and overall survival outcomes compared to patients who had a normal weight, according to data from an exploratory analysis.

In this post, learn more about financial toxicity and how to combat it.

The V Foundation is set to host its annual Dick Vitale Gala on Sept. 4, 2020, virtually, to help raise funds and awareness for pediatric cancer.

A celebrity death reveals how little we really know about breast cancer.

More than half of the patients (61%) admitted to either the hospital or ICU were discharged and 12% remained in the hospital. Nine patients had died by the time data collection was cut off for this study.

Cancer-related cognitive dysfunction affects many survivors. But the right strategies can optimize thinking and memory — and help lift that fog.

Patients with cancer have been encouraged to reach out to legislators and share their personal stories and advocate for why they think continued funding is important to further cancer research.

A three-drug treatment sparked complete responses in more than half of patients with high-risk chronic lymphocytic leukemia, who also tolerated the regimen well.

Discussing the possibility of dying is an unfortunate reality for many patients with cancer and their loved ones, but it isn't a talk that should be avoided. In fact, it can lead to more healing and understanding.

Exploring your story can bring awareness and closure — and help you love this new version of yourself.

A roundup of the latest news and updates for patients with multiple myeloma from CURE®.

After losing the sister she raised to an aggressive type of liver cancer, one woman has devoted herself to stamping out the disease.

A cancer survivor reflects on how the COVID-19 pandemic can feel exhausting but notes that we can still persevere.

“These observations strongly suggest an underdiagnosis of COVID-19 in this population of cancer patients and a major underestimation of SARS-CoV-2 contribution as a cause of death in cancer patients,” the authors wrote. “The management of cancer patients with febrile respiratory symptoms in this period of the epidemic should, therefore, be particularly careful even in the absence of SARS-CoV-2 detection.”

A laryngectomy choir offers rehabilitation and inspiration to patients after throat cancer.

It's important to celebrate the mini-victories along the cancer journey, whether it's with your favorite food or a small parade.

Cancer changes everything about one’s self-image, but that doesn’t mean it is a negative outcome.

Ethan Zohn, "Survivor: Africa" winner, discusses how his winner’s mentality helped him through treatment and how leaning on others has been key in survivorship.

We asked and you answered! Here's what CURE readers had to say about whether or not their care teams helped with crafting a survivorship plan.

U.S. Supreme Court Justice Ruth Bader Ginsburg, 87, has announced that she is currently undergoing chemotherapy for a cancer recurrence.

According to the lead study investigator, work needs to be done to ensure financial toxicity is not a deterrent to clinical trial enrollment and that trial sponsors and payers should consider trial expense reimbursement.